TReatment of Irritable Bowel Syndrome With Diarrhoea Using Titrated ONdansetron Trial (TRITON)
A Randomised, Placebo Controlled Trial to Determine the Efficacy and Mode of Action of Ondansetron in the Treatment of Irritable Bowel Syndrome With Diarrhoea
Sponsor: Barnsley Hospital NHS Foundation Trust
Listed as NCT03555188, this PHASE3 trial focuses on IBS - Irritable Bowel Syndrome and remains completed. Sponsored by Barnsley Hospital NHS Foundation Trust, it has been updated 7 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Sep 2023 — Jul 2024 [monthly]
Completed PHASE3
Status: Unknown Status → Completed
-
Jan 2021 — Sep 2023 [monthly]
Unknown Status PHASE3
-
Jun 2020 — Jan 2021 [monthly]
Unknown Status PHASE3
Status: Recruiting → Unknown Status
▶ Show 2 earlier versions
-
Nov 2018 — Jun 2020 [monthly]
Recruiting PHASE3
-
Jul 2018 — Nov 2018 [monthly]
Recruiting PHASE3
First recorded
Mar 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Barnsley Hospital NHS Foundation Trust
- Barts & The London NHS Trust
- County Durham and Darlington NHS Foundation Trust
- Flinders University
- London North West Healthcare NHS Trust
- Manchester University NHS Foundation Trust
- NHS Lothian
- National Institute for Health Research, United Kingdom
- Queen Mary University of London
- Sandwell & West Birmingham Hospitals NHS Trust
- Sheffield Teaching Hospitals NHS Foundation Trust
- The Leeds Teaching Hospitals NHS Trust
- University College London Hospitals
- University Hospitals of North Midlands NHS Trust
- University of Leeds
- University of Manchester
For direct contact, visit the study record on ClinicalTrials.gov .